Essential Drugs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 12-07-2024
- Paid Up Capital ₹ 4.60 M
as on 12-07-2024
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2021)
- Profit -15322.57%
(FY 2021)
- Ebitda -3312.61%
(FY 2021)
- Net Worth -38.94%
(FY 2021)
- Total Assets 125.12%
(FY 2021)
About Essential Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.60 M, as per Ministry of Corporate Affairs (MCA) records.
Shubhankar Gupta, Rattan Aggarwal, Vijay Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100DL2009PTC188867
- Company No.
188867
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Essential Drugs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubhankar Gupta  | Director | 20-Nov-2017 | Current |
| Rattan Aggarwal | Director | 25-Aug-2017 | Current |
| Vijay Gupta | Director | 26-Mar-2009 | Current |
| Sonu Gupta | Director | 26-Mar-2009 | Current |
Financial Performance of Essential Drugs.
Essential Drugs Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 15322.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 38.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Essential Drugs?
In 2021, Essential Drugs had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sri Dwarika Dheesh Polymers Private LimitedActive 20 years 10 monthsShubhankar Gupta, Vijay Gupta and 1 more are mutual person
Highland Liquors Private LimitedActive 12 years 7 monthsShubhankar Gupta, Vijay Gupta and 1 more are mutual person
- Sri Dwarika Dheesh Mercantile Private LimitedActive 19 years 11 months
Shubhankar Gupta, Rattan Aggarwal and 2 more are mutual person
- Gee Pee Ferro Alloys LimitedActive 26 years 8 months
Rattan Aggarwal, Vijay Gupta and 1 more are mutual person
- Sri Dwarika Dheesh Buildwell Private LimitedActive 19 years 11 months
Rattan Aggarwal, Vijay Gupta and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Essential Drugs?
Unlock and access historical data on people associated with Essential Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Essential Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Essential Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
